Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

cardiovascular · Mechanism Report

Does redox-active iron promote lipid peroxidation and oxidative modification of LDL?

Redox-active iron catalyzes Fenton chemistry that drives lipid peroxidation and converts native LDL into oxidized, atherogenic LDL, posing a direct threat to vascular health.

PlausibleJune 22, 202623 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Redox-active iron can promote lipid peroxidation and oxidative modification of LDL particles.

laying out figure…
0 of 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that labile Fe2+ generates hydroxyl and downstream radicals that initiate and amplify lipid peroxidation, producing reactive lipid breakdown products. It further describes iron binding to apoB-100 and enhanced redox cycling—especially in acidic lysosomes—leading to LDL oxidation and contributing to endothelial ferroptosis and vascular injury.

Verified conclusion

Redox-active iron is a highly reactive catalyst capable of driving cellular lipid damage and modifying circulating lipoproteins, posing a direct threat to vascular health.

Molecular mechanisms of lipid peroxidation

  • Radical generation: Divalent iron ($Fe^{2+}$) in the labile iron pool drives the classical Fenton reaction with hydrogen peroxide, generating highly reactive hydroxyl radicals ($\cdot$OH).
  • Propagation cascade: These radicals abstract hydrogen atoms from membrane polyunsaturated fatty acids (PUFAs), producing lipid radicals ($L^{\cdot}$) and lipid peroxyl radicals ($LOO^{\cdot}$).
  • Amplification: Subsequent $Fe^{2+}$-catalyzed decomposition of lipid hydroperoxides ($LOOH$) yields aggressive alkoxyl radicals ($LO^{\cdot}$). This feedback loop leads to membrane disruption and generates toxic, non-enzymatic end-products like malondialdehyde (MDA) and $F_2$-isoprostanes.

Oxidative modification of LDL and vascular injury

  • ApoB-100 modification: Redox-active iron binds directly to apolipoprotein B-100 (apoB-100) on LDL particles. Local reductants, such as superoxide or homocysteine, reduce $Fe^{3+}$ to $Fe^{2+}$, initiating localized Fenton-type chemistry.
  • Atherogenic transition: This lipid peroxidation yields reactive aldehydes (MDA and 4-hydroxynonenal) that adduct apoB-100, transforming native LDL into highly atherogenic oxidized LDL (oxLDL).
  • Lysosomal acceleration: This reaction is highly accelerated in acidic macrophage lysosomes (pH 4.5–5.0), where enhanced iron solubility drives rapid redox cycling.
  • Endothelial ferroptosis: Accumulating oxLDL and intracellular iron synergistically deplete GPX4 and trigger ferroptosis in vascular endothelial cells, accelerating plaque progression.

Bottom line

  • Redox-active iron directly promotes both systemic lipid peroxidation and the oxidative modification of LDL particles through Fenton chemistry, generating atherogenic oxLDL and driving endothelial cell death via ferroptosis.

References

  1. Hydrogen peroxide and iron ions can modulate lipid peroxidation, apoptosis, and the cell cycle, but do not have a significant effect on DNA double-strand break. — linkinghub.elsevier.com ↗
  2. Current Use of Fenton Reaction in Drugs and Food - PMC — pmc.ncbi.nlm.nih.gov ↗
  3. Fenton Reaction - an overview | ScienceDirect Topics — sciencedirect.com ↗
  4. Lipid Peroxidation and Iron Metabolism: Two Corner Stones ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  5. Labile Iron Pool: The Main Determinant of Cellular Response to ... — pubmed.ncbi.nlm.nih.gov ↗
  6. Hydroxyl radical is produced via the Fenton reaction in ... - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  7. Hydrogen peroxide and iron ions can modulate lipid peroxidation ... — sciencedirect.com ↗
  8. What Is Responsible for the Initiating Chemistry of Iron-Mediated ... — pubs.acs.org ↗
  9. LDL oxidized with iron in the presence of homocysteine/cystine at ... — sciencedirect.com ↗
  10. Oxidation of Low-Density Lipoprotein by Iron at Lysosomal pH - PMC — pmc.ncbi.nlm.nih.gov ↗
  11. Oxidation of Low-Density Lipoprotein by Iron at Lysosomal pH — pubs.acs.org ↗
  12. Oxidized low-density lipoproteins and their contribution to ... — explorationpub.com ↗
  13. Iron as a catalyst of human low-density lipoprotein oxidation - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  14. Mechanisms of metal ion-dependent oxidation of human low density ... — pubmed.ncbi.nlm.nih.gov ↗
  15. Reduction of Copper, but Not Iron, by Human Low Density Lipoprotein (LDL) — linkinghub.elsevier.com ↗
  16. The Fenton Activity of Iron(III) in the Presence of Deferiprone — sciencedirect.com ↗
  17. The isoprostanes—25 years later - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  18. Isoprostane Generation and Function - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  19. Key issues in F2-isoprostane analysis - Portland Press — portlandpress.com ↗
  20. Ferroptosis: the potential value target in atherosclerosis - Nature — nature.com ↗
  21. Iron, lipid peroxidation, and ferroptosis play pathogenic roles in ... — academic.oup.com ↗
  22. Inhibition of ferroptosis alleviates atherosclerosis through attenuating lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cell. — linkinghub.elsevier.com ↗
  23. SREBP‐1‐mediated lipogenesis confers resistance to ferroptosis and improves endothelial injury — faseb.onlinelibrary.wiley.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesAre F2-isoprostanes biomarkers of lipid peroxidation and does oxidized LDL contribute to atherosclerosis?→Plausible10 sourcesDo hs-CRP, Lp-PLA2, and myeloperoxidase reflect different cardiovascular risk signals?→